John Snow Labs
John Snow Labs is a privately held healthcare AI and software company founded in 2015. It provides a healthcare-focused AI production stack comprising Medical Large Language Models, Healthcare NLP, Spark NLP, multimodal de-identification, medical terminology services, OMOP data harmonization, no-code annotation and model evaluation through Generative AI Lab, and Patient Journey Intelligence for longitudinal clinical-data integration and real-world evidence. The company sells primarily to health systems, life-sciences organizations, payers, government agencies, and health-technology companies, with software deployed in customer-controlled environments such as on-premises and private cloud. John Snow Labs states that its technology serves 500+ enterprise customers; its public materials cite more than 3,000 healthcare NLP models, 150+ million downloads of its open-source libraries, and 80+ public case studies. Its market positioning is centered on domain-specific, privacy-conscious and production-oriented healthcare AI rather than general-purpose models; the company reports top placement in the 2026 MarketsandMarkets 360Quadrant assessment for NLP in Healthcare and Life Sciences, although this is a company-reported recognition. Recent product and market developments include the Patient Journey Intelligence platform for regulatory-grade real-world evidence, a 2025 HCC coding engine, medical LLM availability through the Microsoft Azure Marketplace, and the 2025 acquisition of WiseCube for biomedical knowledge-graph and drug-discovery capabilities.
Company Details
- Website
- johnsnowlabs.com
- Headquarters
- Lewes, Delaware, United States
- Founded
- 2015
- Funding
- Undisclosed; public sources indicate no disclosed institutional equity funding. A $299,208 NIH/NIAID
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring